Publication | Closed Access

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia

Hematological MalignancyTransplantationMarrow TransplantationStem Cell TransplantationHematologyImmunologyPre-transplant Imatinib-based TherapyStem Cell TherapiesMedicineCell Transplantation